von Willebrand Factor (vWF)-directed Antibodies

Name
von Willebrand Factor (vWF)-directed Antibodies
Accession Number
DBCAT005686
Description

Not Available

Drugs
DrugDrug Description
CaplacizumabA von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP).
Drugs & Drug Targets
DrugTargetType
Caplacizumabvon Willebrand factortarget